Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aili L Lazaar

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
British Journal of Clinical Pharmacology|December 2, 2015
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitorAili L Lazaar, Lucy Yang, Rebecca L Boardley, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 8, 2017
Identification and characterisation of a salt form of Danirixin with reduced pharmacokinetic variability in patient populationsJackie C Bloomer, Claire Ambery, Bruce E Miller, et al.
Critical Care Medicine|June 24, 2015
A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress SyndromeJason D Christie, Steven Vaslef, Philip K Chang, et al.
Pulmonary Circulation|May 4, 2022
An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertensionMarc A Simon, Kate Hanrott, David C Budd, et al.
European Journal of Anaesthesiology|May 30, 2020
A nebulised antitumour necrosis factor receptor-1 domain antibody in patients at risk of postoperative lung injury: A randomised, placebo-controlled pilot studyJames Ryan, Andrew I Bayliffe, Daniel F McAuley, et al.
Critical Care (London, England)|September 8, 2017
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndromeAkram Khan, Cody Benthin, Brian Zeno, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 29, 2020
Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS CohortMarni Stott-Miller, Hana Müllerová, Bruce Miller, et al.
Critical Care (London, England)|December 11, 2019
Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort studyBrian J Anderson, Carolyn S Calfee, Kathleen D Liu, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
British Journal of Clinical Pharmacology|December 2, 2015
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitorAili L Lazaar, Lucy Yang, Rebecca L Boardley, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 8, 2017
Identification and characterisation of a salt form of Danirixin with reduced pharmacokinetic variability in patient populationsJackie C Bloomer, Claire Ambery, Bruce E Miller, et al.
Critical Care Medicine|June 24, 2015
A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress SyndromeJason D Christie, Steven Vaslef, Philip K Chang, et al.
Pulmonary Circulation|May 4, 2022
An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertensionMarc A Simon, Kate Hanrott, David C Budd, et al.
European Journal of Anaesthesiology|May 30, 2020
A nebulised antitumour necrosis factor receptor-1 domain antibody in patients at risk of postoperative lung injury: A randomised, placebo-controlled pilot studyJames Ryan, Andrew I Bayliffe, Daniel F McAuley, et al.
Critical Care (London, England)|September 8, 2017
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndromeAkram Khan, Cody Benthin, Brian Zeno, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 29, 2020
Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS CohortMarni Stott-Miller, Hana Müllerová, Bruce Miller, et al.
Critical Care (London, England)|December 11, 2019
Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort studyBrian J Anderson, Carolyn S Calfee, Kathleen D Liu, et al.
Pageof 4